Clinical remission of acquired thrombasthenia with low-dose methotrexate in a patient with systemic lupus erythematosus [2]

Mayo Clinic Proceedings

Volumn 81, Issue 4, 2006, Pages 566-567

  Yee, Nelson S ^a   Schuster, Stephen J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ARACHIDONIC ACID; AUTOANTIBODY; COLLAGEN; CORTICOSTEROID; DNA ANTIBODY; FIBRINOGEN RECEPTOR; IMMUNOGLOBULIN; METHOTREXATE; PREDNISONE; RISTOCETIN; THROMBOXANE DERIVATIVE;

ADULT; AUTOIMMUNE HEMOLYTIC ANEMIA; BLEEDING; BLEEDING TIME; CASE REPORT; FEMALE; GLANZMANN DISEASE; HUMAN; LETTER; LOW DRUG DOSE; PNEUMONIA; REMISSION; SPLENECTOMY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 33645688134     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/81.4.566-a     Document Type: Letter

References (4)

1. Niessner H, Clemetson KJ, Panzer S, Mueller-Eckhardt C, Santoso S, Bettelheim P. Acquired thrombasthenia due to GPIIb/IIIa-specific platelet autoantibodies. Blood. 1986;68:571-576.
2. Kamiyama M, Arkel YS, Chen K, Shido K. Inhibition of platelet GPIIb/IIIa binding to fibrinogen by serum factors: studies of circulating immune complexes and platelet antibodies in patients with hemophilia, immune thrombocytopenic purpura, human immunodeficiency virus-related immune thrombocytopenic purpura, and systemic lupus crythematosus. J Lab Clin Med. 1991;117: 209-217.
3. Woods VL Jr, Oh EH, Mason D, McMillan R. Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP. Blood. 1984;63:368-375.
4. Granel B, Swiader L, Veit V, et al. Pseudo-Glanzmann thrombasthenia in the course of autoimmune thrombocytopenic purpura [in French]. Rev Med Interne. 1998;19:823-825.